Nygård S T, Skrede S, Langeland N, Flaatten H K
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.
Acta Anaesthesiol Scand. 2017 Feb;61(2):194-204. doi: 10.1111/aas.12848. Epub 2017 Jan 6.
Most studies of sepsis are from intensive care units (ICUs). We aimed to investigate community-acquired severe sepsis in a broader population, in order to compare patients treated in or outside an ICU .
We performed a 1-year prospective observational study with enrollment of patients from three units; a general ICU, a combined ICU/non-ICU and a medical ward with limited surveillance facilities. Hospital survivors were followed up for 5 years.
Overall, 220 patients were included, of which 107 received ICU treatment. The majority of abdominal (77%, P = 0.003) and genitourinary (81%, P < 0.001) infections were found in ICU and non-ICU patients, respectively. Time to first antibiotic administration was longer in ICU-patients (median 3.5 vs. 2.0 h in non-ICU patients, P = 0.011). ICU developed more organ dysfunctions than non-ICU patients (P < 0.001), nevertheless supportive therapy with vasoactive drugs and non-invasive ventilation was documented in 22% and 27% of the latter. Median hospital length of stay was 15 vs. 9 days (P = 0.001), and hospital and 5-year mortality rates 35% vs. 16% (P = 0.002) and 57% vs. 58% (P = 0.892) among ICU and non-ICU patients, respectively. Increasing age (HR 1.06 (1.04, 1.07) per year, P < 0.001), not care level during hospitalization (HR 1.19 (0.70, 2.02), P = 0.514), influenced long-term survival.
Half of the subjects with community-acquired severe sepsis never received ICU treatment. Still, use of organ supportive therapy outside the ICU was considerable. Hospital mortality was higher, whereas 5-year survival was similar when comparing ICU with non-ICU patients.
大多数脓毒症研究来自重症监护病房(ICU)。我们旨在调查更广泛人群中的社区获得性严重脓毒症,以便比较在ICU内或ICU外接受治疗的患者。
我们进行了一项为期1年的前瞻性观察性研究,纳入来自三个科室的患者;一个普通ICU、一个ICU/非ICU联合科室以及一个监测设施有限的内科病房。对医院幸存者进行了5年的随访。
总体而言,共纳入220例患者,其中107例接受了ICU治疗。腹部感染(77%,P = 0.003)和泌尿生殖系统感染(81%,P < 0.001)大多分别见于ICU患者和非ICU患者。ICU患者首次使用抗生素的时间更长(中位数3.5小时,非ICU患者为2.0小时,P = 0.011)。ICU患者出现的器官功能障碍比非ICU患者更多(P < 0.001),不过后者中有22%和27%记录了使用血管活性药物和无创通气的支持治疗。ICU患者和非ICU患者的中位住院时间分别为15天和9天(P = 0.001),医院死亡率分别为35%和16%(P = 0.002),5年死亡率分别为57%和58%(P = 0.892)。年龄增长(每年HR 1.06(1.04,1.07),P < 0.001)而非住院期间的护理级别(HR 1.19(0.70,2.02),P = 0.514)影响长期生存。
社区获得性严重脓毒症患者中有一半从未接受过ICU治疗。尽管如此,ICU外的器官支持治疗使用相当多。比较ICU患者和非ICU患者时,医院死亡率更高,而5年生存率相似。